Sixty-five female outpatients with FMS diagnosed by a rheumatologist were recruited between January 2011 and May 2012 , and randomised to receive duloxetine 60 mg/day or acetyl L-carnitine 1500 mg/day ( 500 mg t.i.d. ) .